首页 › 基金 › Versant Venture Management, LLC › JBIO
Versant Venture Management, LLC 对 JBIO 的持仓历史
JADE BIOSCIENCES INC · 医疗保健
Versant Venture Management, LLC 在 Q3 2026 的 13F 申报中披露持有 JBIO(JADE BIOSCIENCES INC)991,783 股,市值约 US$13.9M,约占其申报组合的 12.77%,在其申报持仓中市值排名第 4 位。 Versant Venture Management, LLC 最近 6 个申报季度中有 6 个季度披露了 JBIO 持仓,最早可追溯至 Q2 2025。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Versant Venture Management, LLC 对 JBIO 的持仓演变
Versant Venture Management, LLC 于 Q2 2025 首次披露 JBIO 持仓:1,525,820 股(约 US$15.2M)。 该持仓在 Q4 2025 达到峰值 1,525,820 股,市值约 US$23.5M。 在 6 次申报中,Versant Venture Management, LLC 0 次增持、1 次减持、4 次保持不变。 最近一期申报(Q3 2026)显示持股 991,783 股、市值约 US$13.9M。 持仓曾出现大幅变动:Q2 2026 减持约 35% (随后一个季度股价下跌 37%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2025 | 1.53M | $15.24M | 新进 |
| Q3 2025 | 1.53M | $13.17M | 持有 |
| Q4 2025 | 1.53M | $23.54M | 持有 |
| Q1 2026 | 1.53M | $21.44M | 持有 |
| Q2 2026 | 991.78K | $22.04M | 减持 |
| Q3 2026 | 991.78K | $13.93M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 JBIO 与 13F 数据
JBIO(JADE BIOSCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 94 只申报持有 JBIO,申报仓位最大的包括:Fairmount Funds Management LLC (US$101.2M), RA CAPITAL MANAGEMENT, L.P. (US$81.6M), Venrock Adviser, LLC (US$71.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 JBIO 的基金
- Fairmount Funds Management LLC 4.55M 股 · $101.18M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 3.67M 股 · $81.57M · Q2 2026
- Venrock Adviser, LLC 3.22M 股 · $71.56M · Q2 2026
- Bellevue Group AG 3.06M 股 · $67.95M · Q2 2026
- Paradigm Biocapital Advisors LP 2.86M 股 · $63.49M · Q2 2026
- Avidity Partners Management LP 1.70M 股 · $37.79M · Q2 2026
- Soleus Capital Management, L.P. 1.55M 股 · $34.46M · Q2 2026
- BAKER BROS. ADVISORS LP 1.23M 股 · $27.34M · Q2 2026
- Remedium Capital Partners, LLC 1.81M 股 · $25.40M · Q3 2026
- Logos Global Management LP 1.12M 股 · $25.00M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 986.76K 股 · $21.93M · Q2 2026
- Foresite Capital Management VI LLC 886.67K 股 · $19.70M · Q2 2026
更多关于 Versant Venture Management, LLC
常见问题
How long has Versant Venture Management, LLC held JBIO?
Versant Venture Management, LLC has disclosed JBIO holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Versant Venture Management, LLC's current position in JBIO?
As of Q3 2026, Versant Venture Management, LLC holds 991.78K shares of JBIO (JADE BIOSCIENCES INC), valued at $13.93M, representing 12.77% of its reported portfolio and ranking #4.
Has Versant Venture Management, LLC been buying or selling JBIO?
In the latest 13F filing (Q3 2026), Versant Venture Management, LLC held unchanged its position in JBIO. The position peaked in Q4 2025 at 1.53M shares.
Which other funds hold JBIO?
Other major institutional holders of JBIO include Fairmount Funds Management LLC, RA CAPITAL MANAGEMENT, L.P., Venrock Adviser, LLC, among 94 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.